Sr One Capital Management as of Dec. 31, 2024
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 11 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 43.9 | $180M | 2.3M | 76.69 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 10.3 | $42M | 4.0M | 10.55 | |
| CRISPR Therapeutics Common Shares (CRSP) | 10.1 | $41M | 1.0M | 39.36 | |
| Design Therapeutics Common Stock (DSGN) | 9.8 | $40M | 6.5M | 6.17 | |
| Zenas BioPharma Common Stock (ZBIO) | 9.8 | $40M | 4.9M | 8.19 | |
| Mineralys Therapeutics Common Stock (MLYS) | 6.1 | $25M | 2.0M | 12.31 | |
| Alumis Common Stock (ALMS) | 3.8 | $15M | 2.0M | 7.86 | |
| Oruka Therapeutics Common Stock (ORKA) | 2.0 | $8.3M | 430k | 19.39 | |
| Nkarta Common Stock (NKTX) | 2.0 | $8.3M | 3.3M | 2.49 | |
| enGene Holdings Common Shares (ENGN) | 1.2 | $5.0M | 748k | 6.65 | |
| KALA Bio Common Stock (KALA) | 1.0 | $4.2M | 599k | 6.94 |
